Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

Mezavant Shortage in Canada: Current Status

Published August 20, 2026 · Updated August 20, 2026 · 4 min read · Shortage status updates automatically

Quick answer

Mezavant (mesalamine 1.2g extended-release tablets, Takeda Canada) has had shortage reports on Drug Shortages Canada, but a headline or a past report doesn't tell you the status right now. Check the current status for DIN 02297558 directly before assuming either way, and if it's short-supplied, talk to your pharmacist rather than stopping or spacing out your doses on your own — mesalamine is a maintenance medication for ulcerative colitis.

What Mezavant is

Mezavant is the Canadian brand name for mesalamine (mesalazine) 1.2g extended-release tablets, made by Takeda Canada — DIN 02297558. It's a 5-ASA (5-aminosalicylic acid) anti-inflammatory used to treat and maintain remission in ulcerative colitis. Most patients take it as a maintenance medication, meaning consistent daily supply matters more than it would for a short-course drug.

Check the current status, not a past report

Mezavant has appeared on Drug Shortages Canada's reporting system before, and shortages for a specific mesalamine product don't necessarily mean every formulation or manufacturer is affected. Check the current status for DIN 02297558 on MedShort rather than relying on a search result or forum post that may reflect an older report.

Don't stretch out your doses on your own

If your pharmacy is low on Mezavant, don't space out doses or split tablets to make a supply last longer — mesalamine's extended-release formulation is designed to release the drug at a specific rate through the digestive tract, and altering how you take it can reduce how well it controls inflammation. Talk to your pharmacist about your options as soon as you notice a supply problem, not once you're down to your last few tablets.

What a pharmacist can — and can't — do about it

Depending on the shortage, a pharmacist may be able to source Mezavant from another pharmacy or suggest a different mesalamine brand or formulation covered by your plan. Switching to a different 5-ASA product or dosing schedule for ulcerative colitis is a bigger decision than a typical substitution, though, so it often needs your prescriber's input rather than being a straightforward pharmacist swap. See when a pharmacist can substitute during a shortage and when it needs your prescriber instead.

Where to check

Search Mezavant or DIN 02297558 on MedShort for the current status pulled directly from Health Canada's Drug Shortages Canada reporting system — the same source your pharmacy checks.

Related Guides

Latest Canadian Shortage Updates

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

40MG 10MG · DIN 02371030

Resolved

Updated: 2026-09-28

AURO PHARMA INC

80MG · DIN 02533243

Active Shortage

Updated: 2026-09-25

AURO PHARMA INC

25MG 160MG · DIN 02408139

Active Shortage

Updated: 2026-09-25

APOTEX INC

100MG · DIN 02245663

Active Shortage

Updated: 2026-09-25

Guide text last reviewed August 20, 2026; the shortage status shown above is pulled from Health Canada's data and refreshed hourly. MedShort.ca is an independent tracking tool and does not provide medical advice.